biote Corp.
For the period ended Mar 31, 2026. Filed May 11, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 11, 2026
BTMD$1.08-2.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity (Deficit)
| Total | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated · Stockholders’ | |||||||||||
| Additional · Other · Deficit · Non- · Total | |||||||||||
| Class A Common Stock · Class V Voting Stock · Paid-in · Accumulated · Comprehensive · Treasury · Attributable to · controlling · Stockholders’ | |||||||||||
| Shares | Amount | Shares | Amount | Capital | Deficit | Loss | Stock | biote Corp. | Interest | Deficit | |
| Balance at December 31, 2025 | 30,713,367 | $3 | 5,221,653 | $1 | $— | $(49,549) | $(29) | $(8,965) | $(58,539) | $8,142 | $(50,397) |
| Distributions | — | — | — | — | — | — | — | — | — | (405) | (405) |
| Net income | — | — | — | — | — | 2,277 | — | — | 2,277 | 399 | 2,676 |
| Other comprehensive income | — | — | — | — | — | — | 2 | — | 2 | — | 2 |
| Share-based compensation | — | — | — | — | — | 1,758 | — | — | 1,758 | — | 1,758 |
| Class A common stock repurchased | (726,388) | — | — | — | — | — | — | (1,071) | (1,071) | — | (1,071) |
| TRA liability | — | — | — | — | — | (518) | — | — | (518) | — | (518) |
| Balance at March 31, 2026 | 29,986,979 | $3 | 5,221,653 | $1 | $— | $(46,032) | $(27) | $(10,036) | $(56,091) | $8,136 | $(47,955) |
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)
| Total | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated · Stockholders’ | |||||||||||
| Additional · Other · Deficit · Non- · Total | |||||||||||
| Class A Common Stock · Class V Voting Stock · Paid-in · Accumulated · Comprehensive · Treasury · Attributable to · controlling · Stockholders’ | |||||||||||
| Shares | Amount | Shares | Amount | Capital | Deficit | Loss | Stock | biote Corp. | Interest | Deficit | |
| Balance at December 31, 2024 | 31,485,777 | $3 | 5,221,653 | $1 | $— | $(100,297) | $(35) | $(5,600) | $(105,928) | $3,728 | $(102,200) |
| Distributions | — | — | — | — | — | — | — | — | — | (694) | (694) |
| Net income | — | — | — | — | — | 13,718 | — | — | 13,718 | 2,121 | 15,839 |
| Other comprehensive income (loss) | — | — | — | — | — | — | (4) | — | (4) | — | (4) |
| Share-based compensation | — | — | — | — | — | 2,127 | — | — | 2,127 | — | 2,127 |
| TRA liability | — | — | — | — | — | 106 | — | — | 106 | — | 106 |
| Balance at March 31, 2025 | 31,485,777 | $3 | 5,221,653 | $1 | $— | $(84,346) | $(39) | $(5,600) | $(89,981) | $5,155 | $(84,826) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.